Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Revenue Summary of Telesis Bio, Inc.

Telesis Bio, Inc.'s latest annual revenue in 2023 was 27.5 Million USD , up 0.27% from previous year.
Telesis Bio, Inc.'s latest quarterly revenue in 2024 Q1 was 3.44 Million USD , down -50.7% from previous quarter.
Telesis Bio, Inc. reported a annual revenue of 27.43 Million USD in annual revenue 2022, up 148.44% from previous year.
Telesis Bio, Inc. reported a annual revenue of 11.04 Million USD in annual revenue 2021, up 67.93% from previous year.
Telesis Bio, Inc. reported a quarterly revenue of 1.55 Million USD for 2024 Q2, down -54.94% from previous quarter.
Telesis Bio, Inc. reported a quarterly revenue of 5.56 Million USD for 2023 Q3, down -35.69% from previous quarter.

Annual Revenue Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Revenue of Telesis Bio, Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	27.5 Million USD	0.27%
2022	27.43 Million USD	148.44%
2021	11.04 Million USD	67.93%
2020	6.57 Million USD	36.86%
2019	4.8 Million USD	238.38%
2018	1.42 Million USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	3.44 Million USD	-50.7%
2024 Q2	1.55 Million USD	-54.94%
2023 Q3	5.56 Million USD	-35.69%
2023 Q2	8.65 Million USD	36.99%
2023 Q4	6.97 Million USD	25.4%
2023 FY	27.5 Million USD	0.27%
2023 Q1	6.31 Million USD	-33.3%
2022 FY	27.43 Million USD	148.44%
2022 Q1	5.63 Million USD	83.11%
2022 Q4	9.46 Million USD	41.86%
2022 Q3	6.67 Million USD	18.04%
2022 Q2	5.65 Million USD	0.34%
2021 FY	11.04 Million USD	67.93%
2021 Q1	2.32 Million USD	20.13%
2021 Q2	2.85 Million USD	22.56%
2021 Q4	3.07 Million USD	10.48%
2021 Q3	2.78 Million USD	-2.31%
2020 Q1	1.38 Million USD	-64.34%
2020 Q2	1.61 Million USD	16.58%
2020 Q3	1.63 Million USD	1.11%
2020 Q4	1.93 Million USD	18.47%
2020 FY	6.57 Million USD	36.86%
2019 Q4	3.89 Million USD	207.27%
2019 FY	4.8 Million USD	238.38%
2019 Q3	1.26 Million USD	7.84%
2019 Q2	1.17 Million USD	-20.35%
2019 Q1	1.47 Million USD	24.7%
2018 Q1	- USD	0.0%
2018 Q2	- USD	0.0%
2018 Q3	238 Thousand USD	0.0%
2018 Q4	1.18 Million USD	396.64%
2018 FY	1.42 Million USD	0.0%
2017 FY	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q2	- USD	0.0%
2017 Q3	- USD	0.0%
2017 Q4	- USD	0.0%
2016 FY	- USD	0.0%

Peer Revenue Comparison of Telesis Bio, Inc.

Name	Revenue	Revenue Difference
Acutus Medical, Inc.	7.16 Million USD	-283.989%
Biotricity, Inc.	12.06 Million USD	-128.038%
Cell MedX Corp.	- USD	-Infinity%
Dynatronics Corporation	32.53 Million USD	15.445%
Nemaura Medical Inc.	77.04 Thousand USD	-35605.571%
PetVivo Holdings, Inc.	968.7 Thousand USD	-2739.768%
RetinalGenix Technologies Inc.	- USD	-Infinity%
Sonendo, Inc.	43.86 Million USD	37.287%
Talis Biomedical Corporation	412 Thousand USD	-6576.942%
Viveve Medical, Inc.	6.42 Million USD	-328.089%